← Back to catalogue

Alinity m HR HPV

FDA PMA

Class III (US FDA PMA)

PMA P230003

by Abbott Molecular, Inc.

Identity

Trade Name
Alinity m HR HPV FDA PMA
Generic Name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS FDA PMA

Identifiers

PMA Number
P230003 FDA PMA
FDA Product Code
MAQ FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APPR Approved FDA PMA

Alinity m HR HPV is a qualitative in vitro test for the detection of Human Papillomavirus DNA in cervical specimens collected by a health care professional using an endocervical brush/spatula placed in ThinPrep PreservCyt Solution or an endocervical broom placed in SurePath Preservative Fluid. This test identifies high-risk (HR) HPV types 16, 18, 45, while reporting the concurrent detection of the other HR genotypes (31/33/52/58) and (35/39/51/56/59/66/68).

Alinity m HR HPV is indicated for use in routine cervical cancer screening as per professional medical guidelines, including triage of ASC-US cytology, co-testing (adjunctive screening) with cytology, and HPV primary screening of women to assess the risk for cervical pre-cancer and cancer. Patients should be followed-up in accordance with professional medical guidelines, results from prior screening, medical history, and other risk factors.

Frequently asked questions

What HPV types does the Alinity m HR HPV test detect?

The Alinity m HR HPV test identifies high-risk HPV types 16, 18, and 45, while also reporting the concurrent detection of other high-risk genotypes: (31/33/52/58) and (35/39/51/56/59/66/68).

What type of specimens can be used with the Alinity m HR HPV test?

The test uses cervical specimens collected by a health care professional using an endocervical brush/spatula placed in ThinPrep PreservCyt Solution or an endocervical broom placed in SurePath Preservative Fluid.

Is the Alinity m HR HPV test intended for primary HPV screening?

Yes, the test is indicated for HPV primary screening of women to assess the risk for cervical pre-cancer and cancer, as well as for triage of ASC-US cytology and co-testing with cytology, in accordance with professional medical guidelines.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Alinity | Core Laboratory bei Abbott, Alinity | Core Laboratory at Abbott, Alinity n - transfusion.abbott

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P230003 24 fields · synced Sep 18, 2026